市場調査レポート

商品コード

鉄剤の世界市場 2024-2028

Global iron drugs market 2024-2028

出版日: 2024年06月12日
発行: TechNavio
ページ情報: 英文 174 Pages
納期: 即納可能

カスタマイズ可能

価格

PDF (Single User License)

USD 2,500 360,150円

レポートPDFをご購入者の1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 4,000 576,240円

レポートPDFを同一組織内のすべての方にて共有ご使用頂けるライセンスです。ご利用人数に制限はありません。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は制限なく何回でも可能ではありますが、印刷物のご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.06円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

鉄剤市場は2023-2028年に45億8,210万米ドル、予測期間中のCAGRは10.87%で成長すると予測されます。

当レポートでは、鉄剤市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。同市場は、世界の鉄欠乏症の蔓延、全体的な健康維持における鉄の重要性に対する意識の高まり、高齢者人口の増加によって牽引されています。

市場範囲
基準年	2024
終了年	2028
予測期間	2024-2028
成長モメンタム	加速
前年比2024年	9.53%
CAGR	10.87%
増分額	45億8,210万米ドル

本調査では、今後数年間の鉄剤市場成長を牽引する主な要因の一つとして、新興国におけるCKD透析センター数の増加を挙げています。また、鉄剤に関連する最近の動向や、妊娠中の鉄サプリメント使用の増加も、市場の大きな需要につながります。

地域別セグメンテーション
地域別比較
北米：市場規模と予測 2023-2028
欧州：市場規模と予測 2023-2028
アジア：市場規模と予測 2023-2028
世界のその他の地域：市場規模と予測 2023-2028
米国：市場規模と予測 2023-2028
日本：市場規模と予測 2023-2028
中国：市場規模と予測 2023-2028
ドイツ：市場規模と予測 2023-2028
フランス：市場規模と予測 2023-2028
市場機会：地域情勢別

第10章促進要因・課題・機会・抑制要因

市場促進要因
市場の課題
促進要因と課題の影響
市場の機会・抑制要因

第11章競合情勢

概要
競合情勢
混乱の状況
業界のリスク

第12章競合分析

企業プロファイル
企業の市場ポジショニング
Abbott Laboratories
AbbVie Inc.
Covis Pharma GmbH
CSL Ltd.
Daiichi Sankyo Co. Ltd.
GlaxoSmithKline Plc
Hiral Labs Ltd.
McKesson Corp.
Pharmacosmos AS
The Procter and Gamble Co.
Reckitt Benckiser Group Plc
Rockwell Medical Inc.
Sanofi SA
Shield Therapeutics plc
Zydus Lifesciences Ltd.

第13章付録

図表

Exhibits:

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Market Segmentation by Age Group
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Company Market Positioning
Exhibits10: Parent Market
Exhibits11: Data Table on - Parent Market
Exhibits12: Market characteristics analysis
Exhibits13: Value Chain Analysis
Exhibits14: Offerings of companies included in the market definition
Exhibits15: Market segments
Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits20: Historic Market Size - Data Table on Global Iron Drugs Market 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Product Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Age Group Segment 2018 - 2022 ($ million)
Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits25: Five forces analysis - Comparison between 2023 and 2028
Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits31: Chart on Market condition - Five forces 2023 and 2028
Exhibits32: Chart on Product - Market share 2023-2028 (%)
Exhibits33: Data Table on Product - Market share 2023-2028 (%)
Exhibits34: Chart on Comparison by Product
Exhibits35: Data Table on Comparison by Product
Exhibits36: Chart on Oral drug - Market size and forecast 2023-2028 ($ million)
Exhibits37: Data Table on Oral drug - Market size and forecast 2023-2028 ($ million)
Exhibits38: Chart on Oral drug - Year-over-year growth 2023-2028 (%)
Exhibits39: Data Table on Oral drug - Year-over-year growth 2023-2028 (%)
Exhibits40: Chart on IV drug - Market size and forecast 2023-2028 ($ million)
Exhibits41: Data Table on IV drug - Market size and forecast 2023-2028 ($ million)
Exhibits42: Chart on IV drug - Year-over-year growth 2023-2028 (%)
Exhibits43: Data Table on IV drug - Year-over-year growth 2023-2028 (%)
Exhibits44: Market opportunity by Product ($ million)
Exhibits45: Data Table on Market opportunity by Product ($ million)
Exhibits46: Chart on Age Group - Market share 2023-2028 (%)
Exhibits47: Data Table on Age Group - Market share 2023-2028 (%)
Exhibits48: Chart on Comparison by Age Group
Exhibits49: Data Table on Comparison by Age Group
Exhibits50: Chart on Adult - Market size and forecast 2023-2028 ($ million)
Exhibits51: Data Table on Adult - Market size and forecast 2023-2028 ($ million)
Exhibits52: Chart on Adult - Year-over-year growth 2023-2028 (%)
Exhibits53: Data Table on Adult - Year-over-year growth 2023-2028 (%)
Exhibits54: Chart on Pediatric - Market size and forecast 2023-2028 ($ million)
Exhibits55: Data Table on Pediatric - Market size and forecast 2023-2028 ($ million)
Exhibits56: Chart on Pediatric - Year-over-year growth 2023-2028 (%)
Exhibits57: Data Table on Pediatric - Year-over-year growth 2023-2028 (%)
Exhibits58: Market opportunity by Age Group ($ million)
Exhibits59: Data Table on Market opportunity by Age Group ($ million)
Exhibits60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits61: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits62: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits63: Chart on Geographic comparison
Exhibits64: Data Table on Geographic comparison
Exhibits65: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits66: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits67: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits68: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits69: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits70: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits71: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits72: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits73: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits74: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits75: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits76: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits77: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits78: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits79: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits80: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits81: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits82: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits83: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits84: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits85: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits86: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits87: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits88: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits89: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits90: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits91: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits92: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits93: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits94: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits95: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits96: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits97: Chart on France - Market size and forecast 2023-2028 ($ million)
Exhibits98: Data Table on France - Market size and forecast 2023-2028 ($ million)
Exhibits99: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibits100: Data Table on France - Year-over-year growth 2023-2028 (%)
Exhibits101: Market opportunity By Geographical Landscape ($ million)
Exhibits102: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits103: Impact of drivers and challenges in 2023 and 2028
Exhibits104: Overview on criticality of inputs and factors of differentiation
Exhibits105: Overview on factors of disruption
Exhibits106: Impact of key risks on business
Exhibits107: Companies covered
Exhibits108: Matrix on companies position and classification
Exhibits109: Abbott Laboratories - Overview
Exhibits110: Abbott Laboratories - Business segments
Exhibits111: Abbott Laboratories - Key news
Exhibits112: Abbott Laboratories - Key offerings
Exhibits113: Abbott Laboratories - Segment focus
Exhibits114: AbbVie Inc. - Overview
Exhibits115: AbbVie Inc. - Product / Service
Exhibits116: AbbVie Inc. - Key news
Exhibits117: AbbVie Inc. - Key offerings
Exhibits118: Covis Pharma GmbH - Overview
Exhibits119: Covis Pharma GmbH - Product / Service
Exhibits120: Covis Pharma GmbH - Key offerings
Exhibits121: CSL Ltd. - Overview
Exhibits122: CSL Ltd. - Business segments
Exhibits123: CSL Ltd. - Key news
Exhibits124: CSL Ltd. - Key offerings
Exhibits125: CSL Ltd. - Segment focus
Exhibits126: Daiichi Sankyo Co. Ltd. - Overview
Exhibits127: Daiichi Sankyo Co. Ltd. - Product / Service
Exhibits128: Daiichi Sankyo Co. Ltd. - Key news
Exhibits129: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibits130: GlaxoSmithKline Plc - Overview
Exhibits131: GlaxoSmithKline Plc - Business segments
Exhibits132: GlaxoSmithKline Plc - Key news
Exhibits133: GlaxoSmithKline Plc - Key offerings
Exhibits134: GlaxoSmithKline Plc - Segment focus
Exhibits135: Hiral Labs Ltd. - Overview
Exhibits136: Hiral Labs Ltd. - Product / Service
Exhibits137: Hiral Labs Ltd. - Key offerings
Exhibits138: McKesson Corp. - Overview
Exhibits139: McKesson Corp. - Business segments
Exhibits140: McKesson Corp. - Key news
Exhibits141: McKesson Corp. - Key offerings
Exhibits142: McKesson Corp. - Segment focus
Exhibits143: Pharmacosmos AS - Overview
Exhibits144: Pharmacosmos AS - Product / Service
Exhibits145: Pharmacosmos AS - Key offerings
Exhibits146: The Procter and Gamble Co. - Overview
Exhibits147: The Procter and Gamble Co. - Business segments
Exhibits148: The Procter and Gamble Co. - Key news
Exhibits149: The Procter and Gamble Co. - Key offerings
Exhibits150: The Procter and Gamble Co. - Segment focus
Exhibits151: Reckitt Benckiser Group Plc - Overview
Exhibits152: Reckitt Benckiser Group Plc - Business segments
Exhibits153: Reckitt Benckiser Group Plc - Key news
Exhibits154: Reckitt Benckiser Group Plc - Key offerings
Exhibits155: Reckitt Benckiser Group Plc - Segment focus
Exhibits156: Rockwell Medical Inc. - Overview
Exhibits157: Rockwell Medical Inc. - Product / Service
Exhibits158: Rockwell Medical Inc. - Key offerings
Exhibits159: Sanofi SA - Overview
Exhibits160: Sanofi SA - Business segments
Exhibits161: Sanofi SA - Key news
Exhibits162: Sanofi SA - Key offerings
Exhibits163: Sanofi SA - Segment focus
Exhibits164: Shield Therapeutics plc - Overview
Exhibits165: Shield Therapeutics plc - Product / Service
Exhibits166: Shield Therapeutics plc - Key offerings
Exhibits167: Zydus Lifesciences Ltd. - Overview
Exhibits168: Zydus Lifesciences Ltd. - Business segments
Exhibits169: Zydus Lifesciences Ltd. - Key news
Exhibits170: Zydus Lifesciences Ltd. - Key offerings
Exhibits171: Zydus Lifesciences Ltd. - Segment focus
Exhibits172: Inclusions checklist
Exhibits173: Exclusions checklist
Exhibits174: Currency conversion rates for US$
Exhibits175: Research methodology
Exhibits176: Information sources
Exhibits177: Data validation
Exhibits178: Validation techniques employed for market sizing
Exhibits179: Data synthesis
Exhibits180: 360 degree market analysis
Exhibits181: List of abbreviations

Product Code: IRTNTR75415

The iron drugs market is forecasted to grow by USD 4582.1 mn during 2023-2028, accelerating at a CAGR of 10.87% during the forecast period. The report on the iron drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing prevalence of iron deficiency globally, growing awareness about importance of iron in maintaining overall health, and growing geriatric population.

Technavio's iron drugs market is segmented as below:

Market Scope
Base Year	2024
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	9.53%
CAGR	10.87%
Incremental Value	$4582.1mn

By Product

Oral drug
IV drug

By Age Group

Adult
Pediatric

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the growing number of CKD dialysis centers in emerging economies as one of the prime reasons driving the iron drugs market growth during the next few years. Also, growing recent developments related to iron drugs and increasing use of iron supplements in pregnancy will lead to sizable demand in the market.

The report on the iron drugs market covers the following areas:

Iron drugs market sizing
Iron drugs market forecast
Iron drugs market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading iron drugs market vendors that include Abbott Laboratories, AbbVie Inc., Alinter Group Ltd., Alora Pharmaceuticals LLC, Breckenridge Pharmaceutical Inc., Covis Pharma GmbH, CSL Ltd., Daiichi Sankyo Co. Ltd., DSE Health Care Solutions Inc., GlaxoSmithKline PLC, Hiral Labs Ltd., McKesson Corp., NovaFerrum, Pharmacosmos AS, The Procter and Gamble Co., Reckitt Benckiser Group PLC, Rockwell Medical Inc., Sanofi SA, Shield Therapeutics PLC, and Zydus Lifesciences Ltd.. Also, the iron drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. IT presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Market Segmentation by Age Group
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
2.2 Market characteristics
- Market characteristics analysis
2.3 Value chain analysis
- Value Chain Analysis

3 Market Sizing

3.1 Market definition
- Offerings of companies included in the market definition
3.2 Market segment analysis
- Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ million)
- Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global Iron Drugs Market 2018 - 2022
- Historic Market Size - Data Table on Global Iron Drugs Market 2018 - 2022 ($ million)
4.2 Product segment analysis 2018 - 2022
- Historic Market Size - Product Segment 2018 - 2022 ($ million)
4.3 Age Group segment analysis 2018 - 2022
- Historic Market Size - Age Group Segment 2018 - 2022 ($ million)
4.4 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Product

6.1 Market segments
- Chart on Product - Market share 2023-2028 (%)
- Data Table on Product - Market share 2023-2028 (%)
6.2 Comparison by Product
- Chart on Comparison by Product
- Data Table on Comparison by Product
6.3 Oral drug - Market size and forecast 2023-2028
- Chart on Oral drug - Market size and forecast 2023-2028 ($ million)
- Data Table on Oral drug - Market size and forecast 2023-2028 ($ million)
- Chart on Oral drug - Year-over-year growth 2023-2028 (%)
- Data Table on Oral drug - Year-over-year growth 2023-2028 (%)
6.4 IV drug - Market size and forecast 2023-2028
- Chart on IV drug - Market size and forecast 2023-2028 ($ million)
- Data Table on IV drug - Market size and forecast 2023-2028 ($ million)
- Chart on IV drug - Year-over-year growth 2023-2028 (%)
- Data Table on IV drug - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Product
- Market opportunity by Product ($ million)
- Data Table on Market opportunity by Product ($ million)

7 Market Segmentation by Age Group

7.1 Market segments
- Chart on Age Group - Market share 2023-2028 (%)
- Data Table on Age Group - Market share 2023-2028 (%)
7.2 Comparison by Age Group
- Chart on Comparison by Age Group
- Data Table on Comparison by Age Group
7.3 Adult - Market size and forecast 2023-2028
- Chart on Adult - Market size and forecast 2023-2028 ($ million)
- Data Table on Adult - Market size and forecast 2023-2028 ($ million)
- Chart on Adult - Year-over-year growth 2023-2028 (%)
- Data Table on Adult - Year-over-year growth 2023-2028 (%)
7.4 Pediatric - Market size and forecast 2023-2028
- Chart on Pediatric - Market size and forecast 2023-2028 ($ million)
- Data Table on Pediatric - Market size and forecast 2023-2028 ($ million)
- Chart on Pediatric - Year-over-year growth 2023-2028 (%)
- Data Table on Pediatric - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Age Group
- Market opportunity by Age Group ($ million)
- Data Table on Market opportunity by Age Group ($ million)

8 Customer Landscape

8.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2023-2028 (%)
- Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ million)
- Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ million)
- Data Table on US - Market size and forecast 2023-2028 ($ million)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Japan - Market size and forecast 2023-2028
- Chart on Japan - Market size and forecast 2023-2028 ($ million)
- Data Table on Japan - Market size and forecast 2023-2028 ($ million)
- Chart on Japan - Year-over-year growth 2023-2028 (%)
- Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.9 China - Market size and forecast 2023-2028
- Chart on China - Market size and forecast 2023-2028 ($ million)
- Data Table on China - Market size and forecast 2023-2028 ($ million)
- Chart on China - Year-over-year growth 2023-2028 (%)
- Data Table on China - Year-over-year growth 2023-2028 (%)
9.10 Germany - Market size and forecast 2023-2028
- Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Chart on Germany - Year-over-year growth 2023-2028 (%)
- Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.11 France - Market size and forecast 2023-2028
- Chart on France - Market size and forecast 2023-2028 ($ million)
- Data Table on France - Market size and forecast 2023-2028 ($ million)
- Chart on France - Year-over-year growth 2023-2028 (%)
- Data Table on France - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Opportunity/Restraints

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints

11 Competitive Landscape

11.1 Overview
11.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
- Overview on factors of disruption
11.4 Industry risks
- Impact of key risks on business

12 Competitive Analysis

12.1 Companies profiled
- Companies covered
12.2 Market positioning of companies
- Matrix on companies position and classification
12.3 Abbott Laboratories
- Abbott Laboratories - Overview
- Abbott Laboratories - Business segments
- Abbott Laboratories - Key news
- Abbott Laboratories - Key offerings
- Abbott Laboratories - Segment focus
12.4 AbbVie Inc.
- AbbVie Inc. - Overview
- AbbVie Inc. - Product / Service
- AbbVie Inc. - Key news
- AbbVie Inc. - Key offerings
12.5 Covis Pharma GmbH
- Covis Pharma GmbH - Overview
- Covis Pharma GmbH - Product / Service
- Covis Pharma GmbH - Key offerings
12.6 CSL Ltd.
- CSL Ltd. - Overview
- CSL Ltd. - Business segments
- CSL Ltd. - Key news
- CSL Ltd. - Key offerings
- CSL Ltd. - Segment focus
12.7 Daiichi Sankyo Co. Ltd.
- Daiichi Sankyo Co. Ltd. - Overview
- Daiichi Sankyo Co. Ltd. - Product / Service
- Daiichi Sankyo Co. Ltd. - Key news
- Daiichi Sankyo Co. Ltd. - Key offerings
12.8 GlaxoSmithKline Plc
- GlaxoSmithKline Plc - Overview
- GlaxoSmithKline Plc - Business segments
- GlaxoSmithKline Plc - Key news
- GlaxoSmithKline Plc - Key offerings
- GlaxoSmithKline Plc - Segment focus
12.9 Hiral Labs Ltd.
- Hiral Labs Ltd. - Overview
- Hiral Labs Ltd. - Product / Service
- Hiral Labs Ltd. - Key offerings
12.10 McKesson Corp.
- McKesson Corp. - Overview
- McKesson Corp. - Business segments
- McKesson Corp. - Key news
- McKesson Corp. - Key offerings
- McKesson Corp. - Segment focus
12.11 Pharmacosmos AS
- Pharmacosmos AS - Overview
- Pharmacosmos AS - Product / Service
- Pharmacosmos AS - Key offerings
12.12 The Procter and Gamble Co.
- The Procter and Gamble Co. - Overview
- The Procter and Gamble Co. - Business segments
- The Procter and Gamble Co. - Key news
- The Procter and Gamble Co. - Key offerings
- The Procter and Gamble Co. - Segment focus
12.13 Reckitt Benckiser Group Plc
- Reckitt Benckiser Group Plc - Overview
- Reckitt Benckiser Group Plc - Business segments
- Reckitt Benckiser Group Plc - Key news
- Reckitt Benckiser Group Plc - Key offerings
- Reckitt Benckiser Group Plc - Segment focus
12.14 Rockwell Medical Inc.
- Rockwell Medical Inc. - Overview
- Rockwell Medical Inc. - Product / Service
- Rockwell Medical Inc. - Key offerings
12.15 Sanofi SA
- Sanofi SA - Overview
- Sanofi SA - Business segments
- Sanofi SA - Key news
- Sanofi SA - Key offerings
- Sanofi SA - Segment focus
12.16 Shield Therapeutics plc
- Shield Therapeutics plc - Overview
- Shield Therapeutics plc - Product / Service
- Shield Therapeutics plc - Key offerings
12.17 Zydus Lifesciences Ltd.
- Zydus Lifesciences Ltd. - Overview
- Zydus Lifesciences Ltd. - Business segments
- Zydus Lifesciences Ltd. - Key news
- Zydus Lifesciences Ltd. - Key offerings
- Zydus Lifesciences Ltd. - Segment focus

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
13.3 Currency conversion rates for US$
- Currency conversion rates for US$
13.4 Research methodology
- Research methodology
13.5 Data procurement
- Information sources
13.6 Data validation
- Data validation
13.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
13.8 Data synthesis
- Data synthesis
13.9 360 degree market analysis
- 360 degree market analysis
13.10 List of abbreviations
- List of abbreviations

鉄剤の世界市場 2024-2028

Global iron drugs market 2024-2028

目次

第1章エグゼクティブサマリー

第2章市場情勢

第3章市場規模の評価

第4章市場規模実績

第5章ファイブフォース分析

第6章市場セグメンテーション：製品別

第7章市場セグメンテーション：年齢層別

第8章顧客情勢

第9章地域別情勢

第10章促進要因・課題・機会・抑制要因

第11章競合情勢

第12章競合分析

第13章付録

Table of Contents

1 Executive Summary

2 Market Landscape

3 Market Sizing

4 Historic Market Size

5 Five Forces Analysis

6 Market Segmentation by Product

7 Market Segmentation by Age Group

8 Customer Landscape

9 Geographic Landscape

10 Drivers, Challenges, and Opportunity/Restraints

11 Competitive Landscape

12 Competitive Analysis

13 Appendix

鉄剤の世界市場 2024-2028

Global iron drugs market 2024-2028

目次

第1章 エグゼクティブサマリー

第2章 市場情勢

第3章 市場規模の評価

第4章 市場規模実績

第5章 ファイブフォース分析

第6章 市場セグメンテーション：製品別

第7章 市場セグメンテーション：年齢層別

第8章 顧客情勢

第9章 地域別情勢

第10章 促進要因・課題・機会・抑制要因

第11章 競合情勢

第12章 競合分析

第13章 付録

Table of Contents

1 Executive Summary

2 Market Landscape

3 Market Sizing

4 Historic Market Size

5 Five Forces Analysis

6 Market Segmentation by Product

7 Market Segmentation by Age Group

8 Customer Landscape

9 Geographic Landscape

10 Drivers, Challenges, and Opportunity/Restraints

11 Competitive Landscape

12 Competitive Analysis

13 Appendix

第1章エグゼクティブサマリー

第2章市場情勢

第3章市場規模の評価

第4章市場規模実績

第5章ファイブフォース分析

第6章市場セグメンテーション：製品別

第7章市場セグメンテーション：年齢層別

第8章顧客情勢

第9章地域別情勢

第10章促進要因・課題・機会・抑制要因

第11章競合情勢

第12章競合分析

第13章付録